- Home
- IDYA vs NVG Comparison
IDYA vs NVG Comparison
Compare IDYA & NVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- NVG
- Stock Information
- Founded
- IDYA 2015
- NVG 1999
- Country
- IDYA United States
- NVG United States
- Employees
- IDYA N/A
- NVG N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- NVG Investment Managers
- Sector
- IDYA Health Care
- NVG Finance
- Exchange
- IDYA Nasdaq
- NVG Nasdaq
- Market Cap
- IDYA 2.6B
- NVG 2.7B
- IPO Year
- IDYA 2019
- NVG N/A
- Fundamental
- Price
- IDYA $26.91
- NVG $12.38
- Analyst Decision
- IDYA Strong Buy
- NVG
- Analyst Count
- IDYA 12
- NVG 0
- Target Price
- IDYA $53.67
- NVG N/A
- AVG Volume (30 Days)
- IDYA 997.6K
- NVG 568.8K
- Earning Date
- IDYA 11-04-2024
- NVG 01-01-0001
- Dividend Yield
- IDYA N/A
- NVG 4.65%
- EPS Growth
- IDYA N/A
- NVG N/A
- EPS
- IDYA N/A
- NVG N/A
- Revenue
- IDYA $3,922,000.00
- NVG N/A
- Revenue This Year
- IDYA N/A
- NVG N/A
- Revenue Next Year
- IDYA $251.89
- NVG N/A
- P/E Ratio
- IDYA N/A
- NVG N/A
- Revenue Growth
- IDYA N/A
- NVG N/A
- 52 Week Low
- IDYA $24.72
- NVG $9.68
- 52 Week High
- IDYA $47.74
- NVG $12.21
- Technical
- Relative Strength Index (RSI)
- IDYA 45.25
- NVG 31.04
- Support Level
- IDYA $24.72
- NVG $12.44
- Resistance Level
- IDYA $26.86
- NVG $13.27
- Average True Range (ATR)
- IDYA 1.23
- NVG 0.16
- MACD
- IDYA 0.04
- NVG -0.09
- Stochastic Oscillator
- IDYA 46.89
- NVG 1.08
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.
About NVG Nuveen AMT-Free Municipal Credit Income Fund
Nuveen AMT-Free Municipal Credit Income Fund is a diversified, closed-end management investment company. Its objective is to provide current income exempt from regular federal income tax. The Fund invests predominantly in investment grade municipal bonds that are exempt from regular federal income taxes.